A universal product identifier for human drugs. It is assigned a unique 10-digit or 11-digit, 3-segment number: the first segment is a labeler code that identifies the manufacturer; the second segment is a product code that identifies the medication; the third segment is a code that identifies the packaging. The code can be any one of the following configurations: 4-4-2, 5-3-2, or 5-4-1.
A VistA package that provides standardization of the local drug files in all VA medical facilities. Standardization includes the adoption of new drug nomenclature and drug classification, as well as linking the local drug file entries to data in the National Drug Files.
Provides information on drug restrictions, guidelines, and protocols to help assure medications are being used according to formulary specifications.
The group responsible for decisions made at a national level regarding settings in PEPS. This would currently be characterized as the PBM team, but it may include other representatives in the future.
A database maintained in the Austin Automation Center (Austin, Texas). The database receives selected demographic data, encounter-based clinical data, and diagnostic data from VAMCs and enables a detailed analysis of the VHA Outpatient Health Care activity.
National Cemetery Administration
National Council for Prescription Drug Programs
National Center for Patient Safety
National Drug Code
National Drug Data File
National Drug File
NDF Reference Terminology
Naming/Directory Service
National Environment
Specifies the amount and types of a medication needed to complete the items in a Unit Dose Pick List, or specifies the amount and types of additives and solutions needed to complete the items in a Sterile Product Work List.
National Electrical Manufacturers Association
A unique item generated at a local facility or from COTS to be entered into PEPS.
An FDA designation for a drug that is under investigation for use or is new to the market. It is not the molecular equivalent for any drug that is currently under investigation or on the market. A new dosage form or strength of an existing product is not an NME.
Non-formulary
New Molecular Entity
The medications that are defined as commercially available drug products not included in the VA National Formulary.
The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has indicated that all medications, including herbal supplements, over-the-counter (OTC) non-prescription medications, and medications prescribed by providers outside the VA (collectively known as “Non-VA medications”), should be entered in the medical record. The user will be able to enter this information into the medical record so that Providers have a better picture of the medications the Patient is taking and that order checks against these medications can occur. Entering Non-VA medications is not the same as placing orders. Users simply enter information to provide a more complete view of what the Patient is taking.
A medication dose that is required for administration as soon as possible and is normally outside of the standard dosing schedules.
National Patient Care Database Project
Non-Service Connected